News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Immunotherapy Treatment
September 2, 2025
Update on Strategies to Improve Treatment for Triple Negative Breast Cancer
Charles H. Weaver, MD
August 29, 2025
ctDNA Recurrence Monitoring in Endometrial Cancer
Charles H. Weaver, MD
August 3, 2025
Treatment of Stage IV-Metastatic Cervical Cancer
Charles H. Weaver, MD
January 11, 2025
Treatment of Stage III Cervical Cancer
Charles H. Weaver, MD
August 7, 2024
CAR T Cell Therapy for Treatment of Solid Tumors
Charles H. Weaver, MD
October 24, 2023
Keytruda & Other Checkpoint Inhibitors for Triple Negative Breast Cancer
Charles H. Weaver, MD
October 16, 2023
Treatment of Stage II Melanoma
Charles H. Weaver, MD
April 8, 2023
Botensilimab + Balstilimab Produces High Response Rates in Advanced Ovarian Cancer
Charles H. Weaver, MD
January 25, 2023
Tecentriq-Avastin for Early Stage Liver Cancer
Charles H. Weaver, MD
February 9, 2022
Precision Cancer Medicines for Endometrial Cancer
Charles H. Weaver, MD
February 3, 2022
Personalized Immunotherapy for Advanced Breast Cancer with TILS
Charles H. Weaver, MD
September 11, 2021
TILs + Opdivo Produce Remissions in Advanced Lung Cancer
Charles H. Weaver, MD
1
2
3
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
